Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 5/20 | 0.47 |
| ▸ | HTR2B | P41595 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 9/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.43 |
| ▸ | USP2 | O75604 | 7/20 | 0.43 |
| ▸ | HTR3A | P46098 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.43 |
| ▸ | HPGD | P15428 | 7/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.43 |
| ▸ | CASP1 | P29466 | 6/20 | 0.43 |
| ▸ | CASP7 | P55210 | 6/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.42 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.42 |
| ▸ | HTR3B | O95264 | 1/20 | 0.42 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4126532 | 0.99 | HTR7 (0.48) | HTR7HTR2BCYP1A2HIF1AUSP2 | |
| Methylpiperazine SCHEMBL6016489 | 0.92 | TACR1 (0.44) | HTR7HTR2BCYP1A2HIF1AUSP2 | |
| SCHEMBL16466062 | 0.89 | HTR7 (0.47) | HTR7HTR2BCYP1A2HIF1AUSP2 | |
| SCHEMBL4119303 | 0.87 | CYP1A2 (0.48) | CYP1A2HIF1AUSP2HTR3AALDH1A1 | |
| SCHEMBL6016332 | 0.87 | HTR7 (0.45) | HTR7HTR2BCYP1A2HIF1AUSP2 | |
| SCHEMBL4110255 | 0.86 | PIK3CA (0.52) | CYP1A2USP2ALDH1A1HPGDHSD17B10 | |
| Piperazine SCHEMBL6016563 | 0.86 | TACR1 (0.47) | HTR7CYP1A2HIF1AUSP2ALDH1A1 | |
| SCHEMBL4123893 | 0.84 | TACR1 (0.47) | HTR7CYP1A2HIF1AUSP2ALDH1A1 | |
| Piperazine SCHEMBL6016442 | 0.84 | ALDH1A1 (0.44) | HTR7CYP1A2HIF1AUSP2ALDH1A1 | |
| Piperazine SCHEMBL6016624 | 0.83 | ALDH1A1 (0.44) | HTR7CYP1A2HIF1AUSP2HTR3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1187815-B1 | 4-PHENYL-PYRIMIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2006-02-08 | — | — | EP | disclosed |
| US-6274588-B1 | NEUROKININ OR SUBSTANCE P ANTAGONISTS; CENTRAL NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDES; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS | HOFFMANN-LA ROCHE INC. | 2001-08-14 | — | — | US | disclosed |